METHSCOPOLAMINE BROMIDE

METHSCOPOLAMINE BROMIDE was reported 144 times

METHSCOPOLAMINE BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCISION SITE RASH 2 0.0333
1 CHRONIC INFLAMMATORY RESPONSE SYNDROME 1 0.0244
2 SPIGELIAN HERNIA 1 0.0204
3 ARCUS LIPOIDES 1 0.0159
4 ENDOVENOUS ABLATION 1 0.0152
5 NON-PITTING OEDEMA 1 0.0114
6 PARANASAL SINUS HAEMORRHAGE 1 0.0090
7 INFUSION SITE PUSTULE 1 0.0078
8 BLOOD GASTRIN INCREASED 1 0.0078
9 SPEECH SOUND DISORDER 1 0.0058
10 PICA 1 0.0056
11 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
12 IVTH NERVE PARALYSIS 1 0.0042
13 MICROCYTOSIS 1 0.0040
14 CSF PRESSURE INCREASED 1 0.0038
15 DIABETIC GANGRENE 1 0.0035
16 PARAPROTEINAEMIA 1 0.0032
17 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 1 0.0026
18 AMMONIA ABNORMAL 1 0.0025
19 UREAPLASMA INFECTION 1 0.0025
20 ALLERGY TO PLANTS 1 0.0022
21 ORAL LICHEN PLANUS 1 0.0020
22 INCISION SITE PAIN 2 0.0017
23 ADRENAL ADENOMA 1 0.0017
24 ILEAL PERFORATION 1 0.0015
25 STASIS DERMATITIS 1 0.0015
26 OPHTHALMIC MIGRAINE 1 0.0014
27 SINUSITIS FUNGAL 1 0.0012
28 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
29 OVARIAN CANCER METASTATIC 1 0.0012
30 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
31 OVARIAN DISORDER 1 0.0011
32 ANIMAL SCRATCH 1 0.0010
33 COLON ADENOMA 1 0.0010
34 BONE DEMINERALISATION 1 0.0009
35 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
36 INFUSION SITE MASS 1 0.0009
37 SINUS PAIN 2 0.0009
38 RECTAL PROLAPSE 1 0.0008
39 CHRONIC RESPIRATORY FAILURE 1 0.0008
40 CARTILAGE INJURY 2 0.0008
41 HEPATIC INFECTION 1 0.0008
42 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
43 PHARYNGEAL ULCERATION 1 0.0008
44 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
45 INFUSION SITE RASH 1 0.0007
46 NASAL DISCHARGE DISCOLOURATION 1 0.0007
47 INFUSION SITE INDURATION 1 0.0007
48 AGE-RELATED MACULAR DEGENERATION 1 0.0007
49 HISTOPLASMOSIS DISSEMINATED 1 0.0006
50 TONSILLAR HYPERTROPHY 1 0.0006
51 JUGULAR VEIN THROMBOSIS 1 0.0006
52 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
53 REBOUND ECZEMA 1 0.0005
54 POLYCYTHAEMIA 1 0.0005
55 INFUSION SITE BRUISING 1 0.0005
56 CERVICAL DYSPLASIA 1 0.0005
57 ADENOCARCINOMA 1 0.0004
58 EAR DISORDER 2 0.0004
59 ARTHRITIS INFECTIVE 2 0.0004
60 RADIUS FRACTURE 1 0.0004
61 VASODILATATION 1 0.0004
62 CONCUSSION 3 0.0004
63 BLOOD SODIUM INCREASED 1 0.0004
64 PLEURITIC PAIN 1 0.0004
65 VITAMIN B12 DECREASED 1 0.0003
66 BILIARY COLIC 1 0.0003
67 IRITIS 1 0.0003
68 DIABETIC FOOT 1 0.0003
69 INFUSION SITE PRURITUS 1 0.0003
70 BILE DUCT STONE 1 0.0003
71 BACTERIAL SEPSIS 1 0.0003
72 LYMPHOCYTE COUNT INCREASED 1 0.0003
73 INFUSION SITE HAEMORRHAGE 1 0.0003
74 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
75 CHOLECYSTITIS CHRONIC 2 0.0003
76 WOUND COMPLICATION 1 0.0003
77 LEFT VENTRICULAR FAILURE 1 0.0003
78 LARGE INTESTINE POLYP 2 0.0003
79 MACULOPATHY 1 0.0003
80 PARANASAL SINUS DISCOMFORT 1 0.0003
81 PARANASAL SINUS HYPERSECRETION 1 0.0003
82 PROSTATOMEGALY 1 0.0003
83 PNEUMONIA FUNGAL 1 0.0003
84 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
85 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
86 HICCUPS 2 0.0002
87 DIVERTICULUM INTESTINAL 1 0.0002
88 SINUS CONGESTION 3 0.0002
89 VASCULAR DEVICE INFECTION 1 0.0002
90 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
91 SPRUE-LIKE ENTEROPATHY 1 0.0002
92 WEIGHT FLUCTUATION 2 0.0002
93 CATATONIA 1 0.0002
94 INJECTION SITE DISCHARGE 1 0.0002
95 DERMATITIS CONTACT 2 0.0002
96 CHOLECYSTECTOMY 2 0.0002
97 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
98 SINUS HEADACHE 1 0.0002
99 SPINAL OPERATION 2 0.0002
100 PRE-EXISTING CONDITION IMPROVED 1 0.0002
101 HIATUS HERNIA 2 0.0002
102 TOOTH INFECTION 2 0.0002
103 PRODUCT LABEL ISSUE 1 0.0001
104 RESPIRATION ABNORMAL 1 0.0001
105 DUODENAL ULCER 1 0.0001
106 SEASONAL ALLERGY 2 0.0001
107 IRRITABLE BOWEL SYNDROME 3 0.0001
108 VISUAL FIELD DEFECT 1 0.0001
109 ORAL DISORDER 1 0.0001
110 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
111 DRUG DISPENSING ERROR 2 0.0001
112 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
113 BLOOD ALBUMIN DECREASED 1 0.0001
114 RENAL CYST 1 0.0001
115 SCIATICA 2 0.0001
116 MIOSIS 1 0.0001
117 NEURALGIA 3 0.0001
118 POST PROCEDURAL INFECTION 1 0.0001
119 ESCHERICHIA INFECTION 1 0.0001
120 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
121 PSYCHOLOGICAL TRAUMA 1 0.0001
122 URINE OUTPUT DECREASED 1 0.0001
123 SPINAL OSTEOARTHRITIS 1 0.0001
124 WRONG DRUG ADMINISTERED 1 0.0001
125 GASTROINTESTINAL INFECTION 1 0.0001
126 END STAGE RENAL DISEASE 2 0.0001
127 EXOSTOSIS 1 0.0001
128 IRON DEFICIENCY ANAEMIA 1 0.0001
129 LACERATION 1 0.0001
130 LEUKAEMIA 1 0.0001
131 SPUTUM DISCOLOURED 1 0.0001
132 SLEEP APNOEA SYNDROME 2 0.0001
133 COELIAC DISEASE 1 0.0001
134 POOR QUALITY DEVICE USED 1 0.0001
135 SUICIDE ATTEMPT 6 0.0001
136 RIB FRACTURE 2 0.0001
137 TENDERNESS 1 0.0001
138 JOINT DISLOCATION 1 0.0001
139 HEREDITARY ANGIOEDEMA 1 0.0001
140 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
141 GASTROINTESTINAL PAIN 1 0.0001
142 TOOTH FRACTURE 1 0.0001
143 OCULAR DISCOMFORT 1 0.0001
144 BLOOD CALCIUM DECREASED 1 0.0001
145 STATUS EPILEPTICUS 1 0.0001
146 IMPAIRED DRIVING ABILITY 1 0.0001
147 INTERNAL HAEMORRHAGE 1 0.0001
148 POST PROCEDURAL HAEMORRHAGE 1 0.0001
149 SPLENOMEGALY 1 0.0001
150 SPINAL PAIN 1 0.0001
151 BLOOD IRON DECREASED 1 0.0001
152 CHOLECYSTITIS 1 0.0001
153 ACCIDENT 1 0.0001
154 HYPERLIPIDAEMIA 1 0.0001
155 WRIST FRACTURE 1 0.0001
156 NO THERAPEUTIC RESPONSE 1 0.0001
157 ENCEPHALOPATHY 2 0.0001
158 INJECTION SITE DISCOLOURATION 1 0.0001
159 TACHYCARDIA 7 0.0001
160 INFUSION SITE PAIN 1 0.0001
161 ANHEDONIA 2 0.0001
162 IMMUNE SYSTEM DISORDER 1 0.0001
163 DYSMENORRHOEA 1 0.0001
164 IMPAIRED GASTRIC EMPTYING 1 0.0001
165 ABNORMAL DREAMS 2 0.0001
166 DEVICE OCCLUSION 1 0.0001
167 DIALYSIS 1 0.0001
168 SURGERY 4 0.0001
169 PSYCHOTIC DISORDER 2 0.0001
170 HAEMORRHAGE INTRACRANIAL 1 0.0001
171 ECONOMIC PROBLEM 1 0.0001
172 OSTEOPENIA 1 0.0001
173 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
174 RESPIRATORY TRACT CONGESTION 1 0.0001
175 HALLUCINATION, AUDITORY 1 0.0001
176 ULCER 1 0.0001
177 MUSCLE TIGHTNESS 1 0.0001
178 CHOLELITHIASIS 2 0.0001
179 MULTIPLE FRACTURES 1 0.0001
180 STAPHYLOCOCCAL INFECTION 2 0.0001
181 SEIZURE 7 0.0001
182 VIRAL INFECTION 2 0.0001
183 FUNGAL INFECTION 2 0.0001
184 CELLULITIS 3 0.0001
185 CIRCULATORY COLLAPSE 1 0.0001
186 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
187 AMENORRHOEA 1 0.0001
188 INJURY 4 0.0001
189 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
190 INJECTION SITE MASS 2 0.0001
191 DYSGEUSIA 4 0.0001
192 BACTERIAL INFECTION 1 0.0001
193 BLOOD SODIUM DECREASED 1 0.0001
194 COLITIS 2 0.0001
195 FEELING JITTERY 1 0.0001
196 PULMONARY FIBROSIS 1 0.0001
197 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
198 POST PROCEDURAL COMPLICATION 1 0.0001
199 LOWER LIMB FRACTURE 1 0.0001
200 ACUTE RESPIRATORY FAILURE 1 0.0001
201 CONTUSION 5 0.0001
202 GLAUCOMA 1 0.0001
203 HERNIA 1 0.0001
204 HAEMORRHOIDS 1 0.0001
205 KIDNEY INFECTION 1 0.0001
206 MENORRHAGIA 1 0.0001
207 UPPER LIMB FRACTURE 1 0.0001
208 BODY TEMPERATURE INCREASED 1 0.0000
209 SINUSITIS 5 0.0000
210 INTENTIONAL DRUG MISUSE 1 0.0000
211 ROAD TRAFFIC ACCIDENT 2 0.0000
212 MOUTH ULCERATION 1 0.0000
213 HALLUCINATION, VISUAL 1 0.0000
214 JOINT INJURY 1 0.0000
215 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
216 APPLICATION SITE PAIN 1 0.0000
217 APPLICATION SITE PRURITUS 1 0.0000
218 PERICARDIAL EFFUSION 1 0.0000
219 LOCALISED INFECTION 1 0.0000
220 FIBROMYALGIA 1 0.0000
221 DRY EYE 2 0.0000
222 FLUID RETENTION 2 0.0000
223 HYPOPHAGIA 1 0.0000
224 EXPOSURE VIA SKIN CONTACT 1 0.0000
225 RESPIRATORY TRACT INFECTION 1 0.0000
226 ECZEMA 2 0.0000
227 GASTRITIS 1 0.0000
228 INJECTION SITE HAEMORRHAGE 3 0.0000
229 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
230 FREQUENT BOWEL MOVEMENTS 1 0.0000
231 RASH PRURITIC 2 0.0000
232 LIMB INJURY 1 0.0000
233 DIVERTICULITIS 1 0.0000
234 PROCEDURAL PAIN 1 0.0000
235 MEDICATION ERROR 2 0.0000
236 WOUND 1 0.0000
237 EYE PAIN 2 0.0000
238 FLATULENCE 2 0.0000
239 RHEUMATOID ARTHRITIS 4 0.0000
240 INTENTIONAL DOSE OMISSION 1 0.0000
241 INTENTIONAL PRODUCT MISUSE 3 0.0000
242 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
243 ASCITES 1 0.0000
244 WHEEZING 2 0.0000
245 RESPIRATORY DISORDER 1 0.0000
246 EMOTIONAL DISTRESS 4 0.0000
247 STOMATITIS 2 0.0000
248 VERTIGO 2 0.0000
249 DISCOMFORT 2 0.0000
250 LIMB DISCOMFORT 1 0.0000
251 NERVOUS SYSTEM DISORDER 1 0.0000
252 VOMITING 15 0.0000
253 HEAD INJURY 1 0.0000
254 PULMONARY EMBOLISM 3 0.0000
255 MIGRAINE 3 0.0000
256 CYSTITIS 1 0.0000
257 MOOD SWINGS 1 0.0000
258 SWELLING FACE 2 0.0000
259 DYSPEPSIA 3 0.0000
260 IMPAIRED HEALING 1 0.0000
261 EYE DISORDER 1 0.0000
262 INFUSION RELATED REACTION 2 0.0000
263 ABDOMINAL PAIN 7 0.0000
264 DEHYDRATION 4 0.0000
265 SKIN DISORDER 1 0.0000
266 INJECTION SITE PRURITUS 2 0.0000
267 ANGER 1 0.0000
268 URINARY TRACT INFECTION 5 0.0000
269 NIGHTMARE 1 0.0000
270 ABDOMINAL DISTENSION 3 0.0000
271 SLEEP DISORDER 2 0.0000
272 LYMPHADENOPATHY 1 0.0000
273 PLATELET COUNT DECREASED 3 0.0000
274 PRODUCT ADHESION ISSUE 1 0.0000
275 CEREBRAL HAEMORRHAGE 1 0.0000
276 FALL 9 0.0000
277 DYSPNOEA EXERTIONAL 1 0.0000
278 ASTHMA 3 0.0000
279 UNEVALUABLE EVENT 2 0.0000
280 CHRONIC KIDNEY DISEASE 2 0.0000
281 BLOOD PRESSURE INCREASED 4 0.0000
282 PERIPHERAL SWELLING 4 0.0000
283 DECREASED APPETITE 6 0.0000
284 PLASMA CELL MYELOMA 1 0.0000
285 DISORIENTATION 1 0.0000
286 WEIGHT DECREASED 7 0.0000
287 JOINT SWELLING 3 0.0000
288 EXTRA DOSE ADMINISTERED 1 0.0000
289 DRY MOUTH 2 0.0000
290 OEDEMA PERIPHERAL 3 0.0000
291 ANXIETY 7 0.0000
292 BLINDNESS 1 0.0000
293 OSTEOPOROSIS 1 0.0000
294 URTICARIA 4 0.0000
295 ABDOMINAL DISCOMFORT 4 0.0000
296 OSTEOARTHRITIS 1 0.0000
297 RECTAL HAEMORRHAGE 1 0.0000
298 DIARRHOEA 15 0.0000
299 BALANCE DISORDER 2 0.0000
300 MENTAL DISORDER 1 0.0000
301 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
302 MUSCULOSKELETAL STIFFNESS 2 0.0000
303 ANGIOEDEMA 1 0.0000
304 LIVER DISORDER 1 0.0000
305 COLITIS ULCERATIVE 1 0.0000
306 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
307 GASTROINTESTINAL DISORDER 2 0.0000
308 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
309 THERAPY NON-RESPONDER 1 0.0000
310 SKIN DISCOLOURATION 1 0.0000
311 NASOPHARYNGITIS 4 0.0000
312 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
313 OROPHARYNGEAL PAIN 2 0.0000
314 RENAL DISORDER 1 0.0000
315 PAIN 13 0.0000
316 NEUROPATHY PERIPHERAL 2 0.0000
317 PRODUCTIVE COUGH 1 0.0000
318 RASH ERYTHEMATOUS 1 0.0000
319 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
320 LUNG DISORDER 1 0.0000
321 PRODUCT DOSE OMISSION ISSUE 6 0.0000
322 NAUSEA 16 0.0000
323 FLUSHING 2 0.0000
324 CHEST DISCOMFORT 2 0.0000
325 INFLAMMATION 1 0.0000
326 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
327 NERVOUSNESS 1 0.0000
328 PANCREATITIS 1 0.0000
329 DRUG INTERACTION 3 0.0000
330 HYPERTENSION 4 0.0000
331 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
332 OEDEMA 1 0.0000
333 TREATMENT NONCOMPLIANCE 1 0.0000
334 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
335 HAEMATOCHEZIA 1 0.0000
336 FATIGUE 14 0.0000
337 NECK PAIN 1 0.0000
338 BLISTER 1 0.0000
339 OXYGEN SATURATION DECREASED 1 0.0000
340 CEREBROVASCULAR ACCIDENT 3 0.0000
341 MUSCULAR WEAKNESS 2 0.0000
342 DEPRESSION 4 0.0000
343 CONVULSION 1 0.0000
344 LETHARGY 1 0.0000
345 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
346 DYSPHONIA 1 0.0000
347 CHILLS 2 0.0000
348 NASAL CONGESTION 1 0.0000
349 FEELING ABNORMAL 4 0.0000
350 THERAPEUTIC RESPONSE DECREASED 1 0.0000
351 MUSCLE SPASMS 3 0.0000
352 FEELING HOT 1 0.0000
353 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
354 INJECTION SITE ERYTHEMA 2 0.0000
355 HEADACHE 10 0.0000
356 BLOOD GLUCOSE INCREASED 3 0.0000
357 GAIT DISTURBANCE 3 0.0000
358 DEEP VEIN THROMBOSIS 1 0.0000
359 INSOMNIA 4 0.0000
360 NEOPLASM MALIGNANT 1 0.0000
361 HYPOTENSION 3 0.0000
362 HEPATIC ENZYME INCREASED 1 0.0000
363 ABDOMINAL PAIN UPPER 3 0.0000
364 VISION BLURRED 2 0.0000
365 BURNING SENSATION 1 0.0000
366 DEVICE MALFUNCTION 1 0.0000
367 MOBILITY DECREASED 1 0.0000
368 INFECTION 2 0.0000
369 PAIN IN EXTREMITY 4 0.0000
370 EPISTAXIS 1 0.0000
371 ACUTE KIDNEY INJURY 2 0.0000
372 INJECTION SITE SWELLING 1 0.0000
373 INJECTION SITE PAIN 4 0.0000
374 ARTHRITIS 1 0.0000
375 PARAESTHESIA 2 0.0000
376 THROMBOSIS 1 0.0000
377 INFLUENZA LIKE ILLNESS 1 0.0000
378 TREMOR 2 0.0000
379 DIZZINESS 6 0.0000
380 DRUG ABUSE 1 0.0000
381 SKIN EXFOLIATION 1 0.0000
382 MYALGIA 2 0.0000
383 PYREXIA 4 0.0000
384 RASH 5 0.0000
385 OFF LABEL USE 10 0.0000
386 COVID-19 2 0.0000
387 DRUG INEFFECTIVE 15 0.0000
388 DEVICE ISSUE 1 0.0000
389 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
390 SUICIDAL IDEATION 1 0.0000
391 ADVERSE EVENT 1 0.0000
392 COUGH 3 0.0000
393 CARDIAC DISORDER 1 0.0000
394 SWELLING 1 0.0000
395 ANAEMIA 2 0.0000
396 SOMNOLENCE 2 0.0000
397 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
398 HAEMOGLOBIN DECREASED 1 0.0000
399 ERYTHEMA 2 0.0000
400 ILLNESS 1 0.0000
401 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
402 PNEUMONIA 3 0.0000
403 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
404 MALAISE 4 0.0000
405 INFLUENZA 1 0.0000
406 SEPSIS 1 0.0000
407 BACK PAIN 2 0.0000
408 VISUAL IMPAIRMENT 1 0.0000
409 ASTHENIA 3 0.0000
410 LOSS OF CONSCIOUSNESS 1 0.0000
411 HYPERHIDROSIS 1 0.0000
412 RENAL FAILURE 1 0.0000
413 MEMORY IMPAIRMENT 1 0.0000
414 ARTHRALGIA 3 0.0000
415 DYSPNOEA 4 0.0000
416 HYPOAESTHESIA 1 0.0000
417 HOSPITALISATION 1 0.0000
418 DRUG DOSE OMISSION 1 0.0000
419 MYOCARDIAL INFARCTION 1 0.0000
420 NO ADVERSE EVENT 1 0.0000
421 CHEST PAIN 1 0.0000
422 HYPERSENSITIVITY 1 0.0000
423 PRODUCT USE ISSUE 1 0.0000
424 PRURITUS 2 0.0000
425 ALOPECIA 1 0.0000
426 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
427 OVERDOSE 1 0.0000
428 CONSTIPATION 1 0.0000
429 WEIGHT INCREASED 1 0.0000
430 INCORRECT DOSE ADMINISTERED 1 0.0000
431 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
432 CONDITION AGGRAVATED 1 0.0000
433 DEATH 2 0.0000